Cara Therapeutics (CARA) Gains on Wainwright Initiation

Cara Therapeutics Inc (NASDAQ: CARA) shares rose 4.5% to $7.90. H.C. Wainwright initiated coverage on Cara Therapeutics with a buy rating. Share volume was one million, eking out an all-day average of 990,000